Atom Investors’s Guardant Health GH Stock Holding History

Atom Investors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Sell	11,084 -12,473	-53%	-$1.36M	0.15%	217
2026 Q1	$2.18M	Buy	23,557 +3,174	+16%	+$319K	0.16%	228
2025 Q4	$2.08M	Buy	+20,383	New	+$1.82M	0.17%	188
2024 Q2	–	Sell	-13,266	Closed	-$274K	–	551
2024 Q1	$274K	Buy	+13,266	New	+$284K	0.03%	425
2021 Q1	–	Sell	-15,380	Closed	-$1.98M	–	312
2020 Q4	$1.98M	Buy	15,380 +1,440	+10%	+$166K	0.2%	132
2020 Q3	$1.56M	Sell	13,940 -32,730	-70%	-$2.99M	0.15%	150
2020 Q2	$3.79M	Buy	+46,670	New	+$3.76M	0.25%	74
2020 Q1	–	Sell	-57,000	Closed	-$4.45M	–	344
2019 Q4	$4.45M	Buy	+57,000	New	+$4.11M	0.36%	84

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Atom Investors's GH Position: Q2 2026 in Review

Atom Investors reduced its Guardant Health (GH) stake by 53% in Q2 2026, selling an estimated $1.36M and leaving 11,084 shares worth $1.66M. The position accounts for 0.15% of the portfolio, ranked #217.

Atom Investors first reported a position in GH in Q4 2019 and has held it in 8 quarters since. The position peaked at $4.45M in Q4 2019. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Atom Investors held 11,084 shares of Guardant Health worth $1.66M as of Q2 2026.
Atom Investors sold 12,473 Guardant Health shares in Q2 2026, an estimated $1.36M.
Guardant Health made up 0.15% of Atom Investors's portfolio in Q2 2026, its #217 holding.
Atom Investors first reported a position in Guardant Health in Q4 2019 and has held it in 8 quarters since.
Atom Investors's Guardant Health position peaked at $4.45M in Q4 2019.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.